We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Compugen Target for Cancer Immunotherapy Shown to Affect Multiple Immune Cell Types

News   Sep 26, 2013

 
Compugen Target for Cancer Immunotherapy Shown to Affect Multiple Immune Cell Types
 
 
 

RELATED ARTICLES

Scientists Crack the Chemical Code of Complex “Anti-tumor Antibiotic”

News

After 20 years of dedicated research, scientists have cracked the chemical code of an incredibly complex "anti-tumor antibiotic" known to be highly effective against cancer cells as well as drug-resistant bacteria, and have reproduced it synthetically in the lab for the first time.

READ MORE

Targeted Therapy Proves Effective Against Aggressive Blood Cancer in Clinical Trial

News

A multi-institutional clinical trial has given good results for a targeted therapy to treat a rare, aggressive blood cancer known as blastic plasmacytoid dendritic-cell neoplasm (BPDCN).

READ MORE

Exposing and Exploiting Cancer’s Metabolic Addictions

News

Where a tumor arises dictates specific metabolic vulnerabilities, identifying potential targets for effective cancer treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE